Medtronic plc. ($MDT) Stock Forecast: Up 0.7% Today

What is Medtronic plc.?

Medtronic PLC (MDT) is a leading medical technology company specializing in the development and manufacturing of medical devices and therapies. The company focuses on improving healthcare outcomes for patients worldwide.

Why is Medtronic plc. going up?

MDT stock is up 0.7% on Jan 5, 2026 15:51

• Medtronic PLC (MDT) experienced a strong bullish movement today.
• The company exceeded Q3 earnings estimates, reporting $1.36 EPS and $8.96 billion in revenue, and provided a positive forecast for FY26 EPS.
• The market movement could be attributed to a firm lowering its stake in MDT by 9.9% in Q3, potentially signaling confidence in the company's future performance.
• The overall positive sentiment towards AI-powered medical stocks, including MDT, as highlighted in discussions focusing on the integration of AI in the medical sector, could have also contributed to the bullish movement.

MDT Price Chart

MDT Technical Analysis

MDT News

D.A. Davidson & CO. Has $20.33 Million Holdings in Medtronic PLC $MDT

D.A. Davidson & CO. has lowered its stake in Medtronic PLC (NYSE:MDT) by 9.9% in Q3, now holding 213,482 shares valued at $20.33 million. Medtronic exceeded Q3 earnings estimates with $1.36 EPS and $8.96 billion in revenue, forecasting FY26 EPS between $5.62 and $5.66. The company also announced a quarterly dividend of $0.71, translating to an annualized yield of approximately 3.0%.

https://www.marketbeat.com/instant-alerts/filing-da-davidson-co-has-2033-million-holdings-in-medtronic-plc-mdt-2026-01-05/

Watch 5 AI-Powered Medical Stocks for a Strong Portfolio in 2026

This article highlights five AI-powered medical stocks – Eli Lilly (LLY), Medtronic (MDT), Intuitive Surgical (ISRG), Regeneron Pharmaceuticals (REGN), and Johnson & Johnson (JNJ) – for a strong portfolio in 2026. It details how AI has reshaped the medical landscape by revolutionizing diagnostics, treatment, and operational efficiency. Each company's integration of AI into their products, pipeline, and operations is discussed, along with their financial performance and Zacks Ranks.

https://www.theglobeandmail.com/investing/markets/stocks/ISRG/pressreleases/36885348/watch-5-ai-powered-medical-stocks-for-a-strong-portfolio-in-2026/

Watch 5 AI-Powered Medical Stocks for a Strong Portfolio in 2026

This article highlights five AI-powered medical stocks that are projected to build a strong portfolio in 2026. The medical sector has significantly adopted AI for diagnostics, drug synthesis, and operational efficiency, transforming some defensive low-beta stocks into high-growth providers. The featured companies are Eli Lilly and Co. (LLY), Medtronic plc (MDT), Intuitive Surgical Inc. (ISRG), Regeneron Pharmaceuticals Inc. (REGN), and Johnson & Johnson (JNJ), each leveraging AI to enhance their product offerings, operational efficiency, and market position.

https://finviz.com/news/267106/watch-5-ai-powered-medical-stocks-for-a-strong-portfolio-in-2026

US Medical Robotics Market to Grow at 16.2% CAGR, Led by Intuitive

The US Medical Robotics Market is projected to grow at a CAGR of 16.2% from US$63.53 million in 2024 to US$286.99 million by 2033. This growth is driven by advancements in AI and machine learning, increasing demand for minimally invasive procedures, and rising FDA clearances. Key market players include Intuitive Surgical, Stryker Corporation, and Medtronic Plc, with surgical robots dominating the product type segment and general surgery leading by application.

https://www.openpr.com/news/4336212/us-medical-robotics-market-to-grow-at-16-2-cagr-led-by-intuitive

How Investors Are Reacting To Baxter (BAX) Debt Tender Offers And Smart Infusion EMR Data

Baxter International recently completed debt tender offers and released data on smart infusion pump integration with EMR systems, showing improved patient safety and clinician productivity. While the debt reduction is helpful, investors are focusing on Baxter's ability to achieve sustainable profitability and manage operational pressures. The EMR integration highlights innovation but ongoing quality risks with infusion pumps remain a concern for the company's investment narrative.

https://simplywall.st/stocks/us/healthcare/nyse-bax/baxter-international/news/how-investors-are-reacting-to-baxter-bax-debt-tender-offers

Trending Today

Omnicom Group Inc. ($OMC) Stock Forecast: Down 6.2% Today

Equifax Inc. ($EFX) Stock Forecast: Down 9.4% Today

Steel Dynamics Inc. ($STLD) Stock Forecast: Up 5.6% Today

AMETEK Inc. ($AME) Stock Forecast: Up 1.4% Today

Newmont Mining Corporation ($NEM) Stock Forecast: Up 6.0% Today

Cboe Global Markets Inc. ($CBOE) Stock Forecast: Up 2.2% Today

IQVIA Holdings Inc. ($IQV) Stock Forecast: Down 2.6% Today

Martin Marietta Materials Inc. ($MLM) Stock Forecast: Up 3.6% Today

KKR & Co. Inc. Class A ($KKR) Stock Forecast: Down 4.7% Today

Spotify Technology S.A. ($SPOT) Stock Forecast: Down 4.7% Today

Medtronic plc. Price History

04.03.2025 - MDT Stock was down 5.5%

• MDT's stock (MDT) saw a -1.09% decrease, signifying a bearish trend.
• The decline in MDT's stock price may be linked to investors taking profits following a recent uptick.
• Concerns over potential regulatory changes in the healthcare sector could be making investors cautious, resulting in the drop in MDT's stock.
• This bearish movement in MDT's stock is likely a brief correction in response to market conditions rather than an indication of the company's underlying performance.

14.00.2025 - MDT Stock was up 5.2%

• Medtronic experienced a bullish movement, potentially influenced by positive analyst coverage and forecasts for Anteris Technologies, a player in the transcatheter valve replacement market.
• Analysts' positive outlook on Anteris Technologies' DurAVR valve system, expected to gain a significant market share by 2030, likely bolstered investor confidence in the broader medical technology sector.
• The encouragement of innovative technologies in healthcare may have positively impacted Medtronic, leading to an increase in its stock price.
• The optimistic view on advancements in transcatheter valve replacement technologies could be a contributing factor to Medtronic's overall bullish stock performance.

05.00.2026 - MDT Stock was up 0.7%

• Medtronic PLC (MDT) experienced a strong bullish movement today.
• The company exceeded Q3 earnings estimates, reporting $1.36 EPS and $8.96 billion in revenue, and provided a positive forecast for FY26 EPS.
• The market movement could be attributed to a firm lowering its stake in MDT by 9.9% in Q3, potentially signaling confidence in the company's future performance.
• The overall positive sentiment towards AI-powered medical stocks, including MDT, as highlighted in discussions focusing on the integration of AI in the medical sector, could have also contributed to the bullish movement.

20.07.2025 - MDT Stock was up 5.3%

• Medtronic is a multinational medical technology company headquartered in Ireland, known for developing and manufacturing medical devices and equipment.
• The company reported strong Q1 earnings and revenue beats, along with an increased full-year EPS outlook, despite a slight decline in stock price.
• Q1 sales, adjusted EPS, and FY26 sales guidance all surpassed estimates.
• Analysts revised their forecasts ahead of the earnings call, expecting positive results for the company.
• The stock's positive movement today reflects the impact of the encouraging earnings report and raised sales guidance, even amid a minor drop in stock price.

23.09.2025 - MDT Stock was down 3.2%

• Medtronic (MDT) experienced a bearish movement today.
• The market might have reacted negatively due to potential concerns about the company's financial performance or future growth prospects.
• The news about businesses using Giftbit for rewards may not have directly impacted Medtronic's stock price, leading investors to focus on other factors affecting the company.
• Investors may be reevaluating their positions in Medtronic based on broader market trends or specific industry developments.

18.10.2025 - MDT Stock was up 5.1%

• Following its Q2 earnings, Medtronic (MDT) saw a strong upward trend in its stock value, buoyed by exceeding earnings expectations and showcasing robust growth in the Cardiovascular segment.
• The company's revised 2026 outlook also bolstered investors' confidence, leading to a rise in the stock price.
• Analysts' positive forecast adjustments prior to the earnings announcement foreshadowed a strong performance, paving the way for the stock's climb post-earnings.
• Market response indicates investor trust in Medtronic's financial stability and growth opportunities, driving the stock's ascent as optimism for future success grows.

18.10.2025 - MDT Stock was up 6.0%

• Medtronic (MDT) surpassed earnings and revenue forecasts for the second quarter, demonstrating strong financial results.
• Analysts raised their projections before the earnings announcement, indicating confidence in the company's expansion opportunities.
• The optimistic projections for Medtronic's Cardiovascular unit and Diabetes segment potentially influenced the stock's upward movement, highlighting potential growth in these key sectors.
• Overall, investors reacted favorably to Medtronic's robust performance and promising future prospects, leading the stock to climb higher.

21.04.2025 - MDT Stock was down 2.5%

• The stock declined despite surpassing Q4 forecasts and revealing plans to spin off its Diabetes business.
• The market's reaction could be attributed to profit-taking following recent positive developments, leading to a temporary downward trend.
• Investors may be exercising caution concerning the potential implications of the spinoff on Medtronic's operational efficiency and future growth opportunities.
• The stock's drop might also be influenced by broader market conditions or sector-specific factors impacting investor sentiment towards healthcare companies.

17.06.2024 - MDT Stock was up 3.6%

• Forecasts suggest a promising future for the Medical Technology Platform Market, with frontrunners like Medtronic driving innovation. This optimistic projection likely influenced the bullish trend in MDT stock.
• Medtronic's outperformance in market returns reflects investors' trust in the company's capabilities and growth prospects, boosting its stock value.
• The award bestowed upon Medtronic for its commitment to disability inclusion underscores its dedication to diversity and advancement, resonating positively with investors and buoying the stock price.
• In a quest for high-yield dividend opportunities to offset inflation, Medtronic's reliability and growth potential have piqued investors' interest, further fueling the bullish momentum in the stock.

17.06.2024 - MDT Stock was up 3.9%

• Medtronic's bullish movement could be attributed to being a high-yield dividend stock beating inflation, attracting investors looking to counter the effects of rising prices.
• The focus on undervalued healthcare stocks in the market could have positively impacted Medtronic's stock as investors seek opportunities in this sector.
• The integration of AI in healthcare for better patient outcomes could also have contributed to the positive sentiment around healthcare stocks, including Medtronic.
• The search for undervalued breakout stocks in the market may have led investors to discover the potential in companies like Medtronic, driving the bullish movement.

22.04.2025 - MDT Stock was down 5.8%

• Despite delivering strong fourth-quarter fiscal 2025 results with improvements in margins, Medtronic's stock experienced a bearish movement.
• The decision to spin off its Diabetes business into a standalone company could have initially raised concerns among investors about the potential impact on overall performance.
• The beat in Q4 earnings and revenue estimates might not have been substantial enough to offset broader market sentiment or concerns about the upcoming restructuring.
• Investor optimism about Medtronic's strength in the Cardiovascular portfolio may have been overshadowed by uncertainties surrounding the strategic shift in the company's business structure.

01.09.2025 - MDT Stock was down 2.3%

• Medtronic's stock price saw a 1.5% decrease amidst overall market pessimism.
• The larger decline in Medtronic's stock compared to the market suggests company-specific influences.
• Potential factors contributing to the bearish trend may involve earnings discrepancies, regulatory hurdles, or adverse developments impacting investor trust in the company's outlook.